Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Persistent Opioid Use Common Following Surgery

By HospiMedica International staff writers
Posted on 01 May 2017
Approximately six percent of patients continue to use opioids more than three months after their surgery, irrespective of its extent, according to a new study.

Researchers at University of Michigan reviewed U.S. More...
insurance claims data to calculate incidence of persistent opioid use for more than 90 days among opioid-naive patients after minor surgical procedures (such as varicose veins, laparoscopic cholecystectomy and appendectomy, hemorrhoid treatments, and others), as well as following major surgical procedures, such as colectomy, reflux and bariatric surgery, and hysterectomy. The primary outcome was new persistent opioid use, defined as opioid prescription fulfillment 90-180 days after the surgical procedure.

The results showed that of 36,177 patients (average age 45 years, 66% female, 72% Caucasian) who filed claims in 2013-2014, 80% underwent minor surgical procedures. The rates of new persistent opioid use were similar among all patients, however, ranging from 5.9% to 6.5%. By comparison, the incidence of new opioid use in a non-operative control group was only 0.4%. Risk factors for new, persistent opioid use included preoperative tobacco use, alcohol and substance abuse disorders, mood disorders, anxiety, and preoperative pain disorders. The study was published on April 12, 2017, in JAMA Surgery.

“New persistent opioid use after surgery is common and is not significantly different between minor and major surgical procedures but rather associated with behavioral and pain disorders,” concluded lead author Chad Brummett, MD, of the University of Michigan, and colleagues. “This suggests its use is not due to surgical pain but addressable patient-level predictors. New persistent opioid use represents a common but previously underappreciated surgical complication that warrants increased awareness.”

Prescriptions of opioid medications for chronic pain have increased dramatically, a trend that has been accompanied by greatly increased levels of prescription opioid overdose, abuse, addiction, and diversion. While opioid therapy has been found to be associated with alleviation of pain in the short term, most opioid trials do not extend beyond six weeks, and are of limited relevance to long-term opioid use.


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Head Rest
Medifa 61114_3
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The 3D-printed microneedle patch boosts live-virus vaccine delivery (Photo courtesy of IIS/University of Tokyo)

3D-Printed Delivery System Enhances Vaccine Delivery Via Microneedle Array Patch

The COVID-19 pandemic underscored the need for efficient, durable, and widely accessible vaccines. Conventional vaccination requires trained personnel and cold-chain logistics, which can slow mass immunization... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.